Crack The Fat Loss Code Ebook

Sunday, May 31, 2009

Agarikon - Tree Mushroom Tested at Army Lab

By Dr. Markho Rafael

In a fascinating broadcast on National Public Radio, internationally renowned medicinal mushroom expert Paul Stamets tells his story of discovering the medicinal potential of agarikon, an extremely rare and threatened species of wood conk that requires century-old trees to grow. Agarikon is today all but extinct in Europe, its remaining distribution limited to the old growth forests on the North American West Coast.

Knowing that mushrooms are susceptible to many of the same microbes as humans, how could it be, he asked himself, that this perennial wood conk managed to stay healthy for 50 years in the dripping wet rain forest without rotting? It must have a powerful immune system, he concluded, with potentially powerful medicinal compounds that could benefit humans.

To find agarikon in the wild, look for something reminiscent of a beehive on the ancient tree trunks of an old-growth forest. (You may view a picture of agarikon through the agarikon-link on this page.) Please keep in mind that agarikon is a rare and threatened species. Do not harvest it unless there's a very good reason for doing so. But by all means, bring out your digital camera.

Using a proprietary extraction method on his organically cultivated agarikon, Stamets created an agarikon medicinal. He sent a sample of it to the Defense Department for testing within the BIO Shield Program, at a top security lab facility in Ft. Dietrich, Maryland. The BIO Shield Program is dedicated to finding remedies for use against bioterrorism threats and potential biological warfare agents, such as anthrax or smallpox.

Reportedly, tens of thousands of natural as well as manmade remedies are tested through the BIO Shield Program. According to drug discovery supervisor John Seacrest, Paul Stamets agarikon extract scored one of the rare hits against viruses related to smallpox. In other words, it effectively inhibited smallpox related viruses under lab conditions.

Paul Stamets has since applied for a patent on a mushroom-based anti-viral drug. Boston investor John Norris is one of his financial backers. Mr. Norris believes in the project due in part to the fact that some individuals simply are not willing or not able to be vaccinated against smallpox or other potential biological warfare agents.

As a former second at the FDA, John Norris should know enough about the field of medicine. And obviously, his belief in Paul Stamets agarikon extract is strong enough to put his money where his mouth is. His goal is that they may someday sell this agarikon extract for the defense stock-piles of NATO armies, with doses numbering in the hundreds of millions.

That may still be a few years into the future, though. Paul Stamets new mushroom related anti-viral medicine first has to stand up to exhaustive testing, and then eventually be approved for release by the FDA.

Note: The above article is intended for informational purposes only. Agarikon has not been approved by the FDA for use as a medicinal. Never use any herbal or mushroom-product for medicinal purposes unless advice to do so by a licensed medical practitioner.

Reference: Tom Banse, NPR Morning Edition, Smallpox Defense May Be Found in Mushrooms, August 4, 2005. - 17268

About the Author:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home